Viatris Inc. is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Companyâs Antiretroviral medicines (ARV) franchise. Its pipeline and research and development capabilities include expertise in formulation, device development, toxicology, analytical, clinical, bioanalytical, medical affairs, product safety and risk management across a range of therapeutic areas. It produces oral solid doses, injectables, and products with complex dosage forms.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļVTRS
āļāļ·āđāļāļāļĢāļīāļĐāļąāļViatris Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļFeb 01, 1973
āļāļĩāļāļĩāđāļSmith (Scott A)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ32000
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļFeb 01
āļāļĩāđāļāļĒāļđāđ1000 Mylan Boulevard
āđāļĄāļ·āļāļCANONSBURG
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ15317
āđāļāļĢāļĻāļąāļāļāđ17245141465
āđāļ§āđāļāđāļāļāđhttps://www.viatris.com/en
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļVTRS
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļFeb 01, 1973
āļāļĩāļāļĩāđāļSmith (Scott A)
Mr. Brian Roman
Chief Legal Officer
Mr. Paul B. Campbell
Interim Chief Financial Officer
Interim Chief Financial Officer
Mr. Paul B. Campbell
Interim Chief Financial Officer
Interim Chief Financial Officer
Mr. Andrew Enrietti
Chief Administrative and Transformation Officer
Chief Administrative and Transformation Officer
Mr. Andrew Enrietti
Chief Administrative and Transformation Officer
Chief Administrative and Transformation Officer
Mr. Richard A. Mark, CPA
Independent Director
Mr. Richard A. Mark, CPA
Independent Director
Mr. Wyllie Don Cornwell
Independent Director
Mr. Wyllie Don Cornwell
Independent Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Brian Roman
Chief Legal Officer
Mr. Paul B. Campbell
Interim Chief Financial Officer
Interim Chief Financial Officer
Mr. Paul B. Campbell
Interim Chief Financial Officer
Interim Chief Financial Officer
Mr. Andrew Enrietti
Chief Administrative and Transformation Officer
Chief Administrative and Transformation Officer
Mr. Andrew Enrietti
Chief Administrative and Transformation Officer
Chief Administrative and Transformation Officer